<DOC>
	<DOCNO>NCT01004042</DOCNO>
	<brief_summary>The primary objective study determine alteration quality life self-steem BOTOX速 injection glabella depress non-depressed patient . The secondary objective study : - elaborate description muscle involve Veraguth Fold - evaluate depressive symptom use Beck Depression Inventory Botox速 injection . - elucidate depression contraindication botulinum toxin injection .</brief_summary>
	<brief_title>Evaluation Quality Life Self-steem After Botox速 Depressed Non-depressed Patients</brief_title>
	<detailed_description>The study consist two group : one diagnosis depression ( diagnostic criterion DSM-IV-TR MINI International Neuropsychiatric Interview - Brazilian version 5.0 ) without diagnosis depression . Subjects depression part group 1 . They must use therapeutic dose antidepressant least 2 month intervention prescribe psychiatrist . Subjects diagnosis depression part group 2 . Subjects include study receive injection 20 U ( minimal dose ) 40 U ( maximum dose ) BTX-A ( BOTOX速/Allergan , USA ) dilute 0.9 % saline , accord standard injection 4U 5 point glabellar area treatment . Four visit schedule . Visit 0 ( baseline ) , Visit 1 ( intervention ) , visit 2 ( 4 week ) , visit 3 ( 8 week ) visit 4 ( 12 week ) . The scale assessment depressive symptom , Beck Depression Inventory ( BDI ) , apply visit 1,2,3,4 ; WHOQOL BREF apply baseline visit 4 . Rosenberg Self-Esteem Scale apply visit . Photographs take well dermatological evaluation wrinkle fold assess use 4-points validated Severity Wrinkles Scale , psychiatric evaluation well , group .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>1 . Female subject , age 25 60 year ; 2 . Subjects diagnose major depression accord criterion DSMIV , MINI International Neuropsychiatric Interview ( MINI Brazilian version 5.0.0 ) ; 3 . Subjects administer therapeutic dose approve , prescribe antidepressant medication ( pattern dose literature ) , use mention medication stable therapeutic dose least three month prior randomization visit ; 4 . Subjects mild ( 1 ) , moderate ( 2 ) severe ( 3 ) glabellar frown line rest accord Severity Wrinkles Scales ; 5 . Female subject childbearing age present negative urine pregnancy test use effective contraceptive method ; 6 . Subjects never receive botulinum toxin A previously ; 7 . Subjects agree take part study , fully inform purpose nature investigation sign informed consent form ; 8 . Subjects available throughout duration study ; 9 . Subjects sufficient school awareness enable cooperate degree require protocol ; 10 . Subjects Critical appreciation preserve , attest assistant psychiatrist ( group1 ) ; 11 . Subjects reside family member assume coresponsibility study . 1 . Subjects whose medical history physical examination present clinical pathology , myasthenia gravis , EatonLambert Syndrome , neoplasm , muscular disease , motor neuron disease , systemic autoimmune neurological disease ; 2 . Pregnant woman breastfeed , woman plan become pregnant 3 . Subjects suicide risk ; 4 . Subjects addict alcohol illegal drug within last 6 month ; 5 . Subjects use amino glycoside penicillamine antibiotic , quinine Ca2+ channel blocker ; 6 . Subjects use medication , opinion investigator may cause depression , betablockers , oral corticosteroid interferon ; 7 . Subjects , opinion investigator , may potentially require psychiatric hospitalization course study ; 8 . Subjects inflammation active infection area inject ; 9 . Subjects history nonadherence medical treatment , demonstrate unwillingness adhere study protocol ; 10 . The presence additional active DSMIV Axis I diagnosis , mental retardation ; 11 . History psychiatric hospitalization within past three year .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Depression</keyword>
	<keyword>Botulinum toxin</keyword>
	<keyword>Glabella</keyword>
	<keyword>Quality life</keyword>
	<keyword>Self-steem</keyword>
</DOC>